Track Eyenovia, Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Eyenovia, Inc. Common Stock HYPD Open Eyenovia, Inc. Common Stock in new tab

3.25 USD
EPS
-9.40
P/B
0.68
ROE
-324.09
Beta
2.82
Target Price
6.28 USD
Eyenovia, Inc. Common Stock logo

Eyenovia, Inc. Common Stock

🧾 Earnings Recap – Q3 2025

Hyperion DeFi's Q3 2025 results reflect a successful pivot to a leading digital asset treasury firm, marked by significant revenue generation and strategic partnerships within the Hyperliquid ecosystem.

  • Hyperion DeFi established a digital asset treasury anchored by 34.25 million HYPE tokens, valued at approximately $1.45 billion.
  • Daily trading volume on Hyperliquid exceeds $12 billion, with cumulative fees surpassing $700 million since inception.
  • Launched first HYPE Asset Use Service agreement with Credo Payment, enabling cost reductions for institutional clients while monetizing HYPE stake.
  • Appointed David Knox as CFO to enhance institutional product development leveraging Hyperliquid’s infrastructure.
  • Plans to capture growing market share in decentralized derivatives with innovative financial services and compliance-focused strategies.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateApril 21, 2026
EPS-9.40
Book Value4.73
Price to Book0.68
Debt/Equity20.74
% Insiders33.457%
Growth
Revenue Growth16.66%
Estimates
Target Mean Price6.28

DCF Valuation

Tweak assumptions to recompute fair value for Eyenovia, Inc. Common Stock (HYPD)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Eyenovia, Inc. Common Stock Logo Eyenovia, Inc. Common Stock Analysis (HYPD)

Official Website Stock

Is Eyenovia, Inc. Common Stock a good investment? Eyenovia, Inc. Common Stock (HYPD) is currently trading at 3.25 USD. Market analysts have a consensus price target of 6.28 USD. This suggests a potential upside from current levels.

Earnings Schedule: Eyenovia, Inc. Common Stock is expected to release its next earnings report on April 21, 2026.

Investor FAQ

Does Eyenovia, Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Eyenovia, Inc. Common Stock?

Eyenovia, Inc. Common Stock is classified as a Stock.

When is the next earnings date?

The next earnings date is projected to be April 21, 2026. The company currently has a trailing EPS of -9.40.

Company Profile

Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi; and agreement with Formosa Pharmaceuticals. Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in New York, New York.

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
Feb. 3, 2025 0.010000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion